Gayer Charles K bought BCRX
December 22, 2025 · Form 4 insider transaction
Gayer Charles K bought 50,000 shares of BioCryst Pharmaceuticals, Inc. at $5.51 per share, a transaction worth $275.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$5.51
Total value
$275.5K
InsiderGayer Charles K
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after952,583
OwnershipDirect
10b5-1 planNo
AmendedNo